MYCN and neuroblastoma: CGH, for instance, has been used on NB cell lines to confirm the presence of MYCN amplification as well as a combination of unique chromosomal aberrations: 17q gain and deletions at 1p36, 3p, 4p, 9p, 11q, and 14q regions [24,25].